GOSS Gossamer Bio Corp. Total Debt to Capital
Gossamer Bio, Inc. (GOSS) develops innovative treatments for inflammatory pathologies, leveraging a robust scientific foundation. The debt-to-equity ratio reflects the market reaction to such data, where the value of 0.00 captures the metric level. Risks are being mitigated by expanding patient cohorts in trials, although management is currently adjusting the overall development strategy.
Analytical breakdowns and data insights for company Gossamer Bio Corp. (GOSS)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Comprehensive company analysis:GOSS - Gossamer Bio
The total debt-to-equity ratio measures the proportion of borrowed funds within the asset financing structure. Gossamer Bio, Inc. (GOSS) expenditures on complex biomaterial logistics during clinical trials may impact its credit load. By analyzing the degree of equity leverage on GURU.Markets, an investor gains a real-time assessment of the balance of liabilities. This trend captures the extent to which development depends on external loans, which ultimately determines the overall financial stability of the issuer.
Main competitors
Debt to Equity argenx ARGX|Aggregate Debt to Equity BioNTech Inc.|Abivax SA (ABVX) - Total Debt to Capital|All Debt to Shareholders' Equity Ratio ADMA Corp (ADMA)|Total Debt to Capital PTGX (Protagonist Therapeutics)|immunovant.com - Total Debt to Capital|Debt to Equity Kiniksa (KNSA)|GRFS: All Debt to Shareholders' Equity Ratio|ADPT (Adaptive Biotechnologies Corp) - Debt to Equity|Celldex Corp (CLDX) - Total Debt to Equity Ratio|AUPH (Aurinia Pharmaceuticals) - Total Debt to Capital|Total Debt to Capital biocryst.com (BCRX)|Vera Therapeutics (VERA) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Dianthus Therapeutics Inc (DNTH)|Total Debt to Capital PHVS|AbCellera - Total Debt to Capital Coefficient|TRML: Debt to Equity|PGEN: Total Debt to Equity Ratio|PHAR (Pharming Group) - Debt to Equity|Total Debt to Equity Ratio Nektar Therapeutics Inc|UPB (Upstream Bio Corp) - Total Debt to Equity Ratio|Total Debt to Capital ZBIO|Debt to Equity Immunome, Inc. IMNM|Debt to Equity Ratio kalvista.com (KALV)|SEPN: Total Debt to Capital|Debt to Capital Pieris Pharma PVLA|Total Debt to Capital SVRA|RIGL: Debt to Capital Ratio|Debt to Equity ANAB|ATXS (astriatx.com) - Debt to Capital|ENGN: Debt to Equity|Total Debt to Capital Coefficient RAPT|JBIO (Aerovate Therapeutics Inc) - Debt to Equity|Total Debt to Capital Coefficient Aclaris Therapeutics, Inc (ACRS)|Total Debt to Capital KYTX (Kyverna Therapeutics)|tizianalifesciences.com - Total Debt to Capital|CABA: Debt to Equity|VTYX - Total Debt to Equity Ratio|Total Debt to Capital THTX|AVTX (Avalo Therapeutics Inc) - Debt to Capital|ELDN - Debt to Equity|All Debt to Shareholders' Equity Ratio agenusbio.com (AGEN)|Climb Bio (CLYM) - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Zura Bio Ltd (ZURA)|Total Debt to Capital aTyr ATYR|Debt to Equity Adagene Inc ADAG|Total Debt to Capital IMA (Ikena Oncology, Inc.)|STTK: Total Debt to Capital Coefficient|Debt to Equity EQ|Debt to Capital Connect Biopharma Holdings Limited|IMUX - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Atara Biotherapeutics Inc|IFRX (InflaRx N.V.) - Total Debt to Capital|Total Debt to Capital Coefficient XFOR (x4pharma.com)|ACET - Debt to Equity|Debt to Equity Ratio Celularity Inc CELU|INMB: Total Debt to Capital|Barinthus Biotherapeutics Corp (BRNS) - Total Debt to Equity Ratio|Kezar Life Sciences - Total Debt to Equity Ratio|sabbiotherapeutics.com (SABS) - Total Debt to Capital Coefficient|Akari Therapeutics Plc - Total Debt to Capital|Debt to Capital Ratio ENLV|Q32 Bio Inc. - Debt to Equity|Debt to Capital GOVX (GeoVax Corp)|Debt to Equity EDSA|ibioinc.com - Total Debt to Capital Coefficient|Debt to Equity CARM (Carisma Tx)|XTLB: Total Debt to Capital Coefficient|Debt to Equity boltbio.com (BOLT)|HCW Biologics (HCWB) - Aggregate Debt to Equity|APVO - Total Debt to Capital|All Debt to Shareholders' Equity Ratio AIM ImmunoTech, Inc.|Total Debt to Capital ADTX|Total Debt to Capital GRI (GRI Bio Inc)|Debt to Equity XORTX|Vyome Therapeutics - All Debt to Shareholders' Equity Ratio|REVB: Debt to Equity|INDP - Total Debt to Equity Ratio|SCNI: Total Debt to Capital|Total Debt to Capital CalciMedica|AFMD - Total Debt to Equity Ratio|All Debt to Shareholders' Equity Ratio Allakos Therapeutics|HOOK (HOOKIPA Pharma Inc.) - Total Debt to Capital|Total Debt to Capital Coefficient IGMS (igmbio.com)|iTeos Therapeutics, Inc. - Debt to Equity|Ocean Biomedical Inc - Total Debt to Equity Ratio|TCBP: Debt to Equity|Third Harmonic Bio Inc (THRD) - Total Debt to Equity Ratio